Neuronetics (STIM) Free Cash Flow Growth (1y) (2018 - 2026)
Neuronetics (STIM) Free Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -14.34% |
| 10 | Neuronetics | 223.77 Mn | 204.34 Mn | 21.22 Mn | 62.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.06% |
| Mar 31, 2026 | 43.54% |
| Dec 31, 2025 | 108.01% |
| Sep 30, 2025 | 73.94% |
| Jun 30, 2025 | 29.93% |
| Mar 31, 2025 | -39.35% |
| Dec 31, 2024 | -483.22% |
| Sep 30, 2024 | 44.43% |
| Jun 30, 2024 | 48.08% |
| Mar 31, 2024 | 20.86% |
| Dec 31, 2023 | 161.87% |
| Sep 30, 2023 | -31.63% |
| Jun 30, 2023 | 3.81% |
| Mar 31, 2023 | -16.53% |
| Dec 31, 2022 | 44.54% |
| Sep 30, 2022 | 7.38% |
| Jun 30, 2022 | -48.13% |
| Mar 31, 2022 | -41.71% |
| Dec 31, 2021 | -401.23% |
| Sep 30, 2021 | -90.88% |